PharmExec Blog

M&A Round-up • 3/25/2009

The latest round of merger and acquisition activities courtesy of our friends at Pharm Exec Europe:

• Just days after its purchase of Genentech, Roche has made another acquisition, albeit a much smaller one, of the German firm Innovatis. Roche will pay EUR 15 million for the cell analytics company.

• Oxford Gene Technology (OGT) is to acquire Sense Proteomic, a UK-based company engaged in the discovery of disease-specific biomarkers based on its innovative functional protein array technology.

• ACM-Pivotal, which provides clinical trials services to the pharmaceutical and biotech industries, has been acquired by its US counterpart for an undisclosed sum. Following a management buy-out in 2005, Pivotal and ACM Medical Laboratories formed an alliance to extend their global capabilities and have been operating as ACM-Pivotal for the past three years.

• US-based contract research organization (CRO) Covance has expanded its clinical pharmacology footprint in Europe by acquiring Swiss Pharma Contract (SPC), a clinical research company based in Basel, for an undisclosed sum.

This entry was posted in Deals and tagged , , , , , , , , , , . Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

  • Categories

  • Meta